HIV entry inhibitors (Consensus)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIV entry inhibitors (Consensus)
Drug Alias NameCPI-1221CPI-1365
ClassificationSmall molecules
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonistsC-C chemokine receptor type 5 antagonistsHIV fusion inhibitors
TargetsC-C chemokine receptor type 5C-X-C motif chemokine receptor 4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConsensus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConsensus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A